Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2021.02.008
PubMed Identifier: 33691122
Publication URI: http://europepmc.org/abstract/MED/33691122
Type: Journal Article/Review
Volume: 28
Parent Publication: Cell chemical biology
Issue: 5
ISSN: 2451-9448